244 related articles for article (PubMed ID: 10742150)
21. Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury.
Esfandiarei M; Suarez A; Amaral A; Si X; Rahmani M; Dedhar S; McManus BM
Circ Res; 2006 Aug; 99(4):354-61. PubMed ID: 16840719
[TBL] [Abstract][Full Text] [Related]
22. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
[TBL] [Abstract][Full Text] [Related]
23. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
25. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
26. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
27. Coxsackievirus infection of mice. I. Viral kinetics and histopathological changes in mice experimentally infected with coxsackieviruses B3 and B4 by oral route.
Bopegamage S; Borsanyiová M; Vargová A; Petrovicová A; Benkovicová M; Gomolcák P
Acta Virol; 2003; 47(4):245-51. PubMed ID: 15068380
[TBL] [Abstract][Full Text] [Related]
28. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
29. Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3.
Chapman NM; Romero JR; Pallansch MA; Tracy S
J Med Virol; 1997 Jul; 52(3):258-61. PubMed ID: 9210033
[TBL] [Abstract][Full Text] [Related]
30. Proapoptotic protein Siva binds to the muscle protein telethonin in cardiomyocytes during coxsackieviral infection.
Mihatsch K; Nestler M; Saluz HP; Henke A; Munder T
Cardiovasc Res; 2009 Jan; 81(1):108-15. PubMed ID: 18849585
[TBL] [Abstract][Full Text] [Related]
31. [Effect of a C-type CpG ODN on CVB3-infected mice].
Yang L; Sun WQ; Wang L; Wang XL; Wan M; Yu YL; Wang LY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):115-7. PubMed ID: 19174007
[TBL] [Abstract][Full Text] [Related]
32. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
33. Genetics of coxsackievirus B3 cardiovirulence.
Tracy S; Tu Z; Chapman N; Hufnagel G
Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
[TBL] [Abstract][Full Text] [Related]
34. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
[TBL] [Abstract][Full Text] [Related]
35. The role of transgenic knockout models in defining the pathogenesis of viral heart disease.
Liu P; Penninger J; Aitken K; Sole M; Mak T
Eur Heart J; 1995 Dec; 16 Suppl O():25-7. PubMed ID: 8682095
[TBL] [Abstract][Full Text] [Related]
36. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability.
Esfandiarei M; Boroomand S; Suarez A; Si X; Rahmani M; McManus B
Cell Microbiol; 2007 Oct; 9(10):2358-71. PubMed ID: 17848167
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
38. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
39. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
[TBL] [Abstract][Full Text] [Related]
40. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
